Cognex's (CGNX) "Neutral" Rating Reiterated at DA Davidson

Key Points

• DA Davidson reiterated its Neutral rating on Cognex and maintained a $65 price target, implying 12.44% upside from the prior close.
• Cognex reported quarterly EPS of $0.45, beating expectations of $0.42, while revenue reached $291.26 million and increased 16.9% year over year.
• Analyst views remain mixed, but Cognex has a consensus rating of Moderate Buy and an average price target of $75.50; institutional investors own 88.12% of the stock.

Cognex (NASDAQ:CGNX - Get Free Report)'s stock had its "neutral" rating reiterated by DA Davidson in a research note issued on Wednesday, Benzinga reports. They presently have a $65.00 price target on the scientific and technical instruments company's stock. DA Davidson's price objective would suggest a potential upside of 12.44% from the stock's previous close.

Several other brokerages also recently commented on CGNX. Cantor Fitzgerald raised their target price on Cognex from $76.00 to $84.00 and gave the stock an "overweight" rating in a research note on Friday, August 7th. Robert W. Baird reduced their target price on Cognex from $78.00 to $70.00 and set a "neutral" rating for the company in a research report on Wednesday. Citigroup reaffirmed a "neutral" rating and issued a $74.00 price target (up from $72.00) on shares of Cognex in a report on Friday, August 7th. Barclays restated an "overweight" rating and issued a $80.00 price objective (up from $75.00) on shares of Cognex in a research report on Monday, August 10th. Finally, Zacks Research raised shares of Cognex from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, June 16th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and six have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Cognex currently has an average rating of "Moderate Buy" and a consensus price target of $75.50.

Cognex Stock Down 2.0%

NASDAQ CGNX opened at $57.81 on Wednesday. Cognex has a 52 week low of $34.60 and a 52 week high of $72.88. The business has a 50 day moving average price of $62.50 and a 200-day moving average price of $60.33. The company has a market cap of $9.72 billion, a price-to-earnings ratio of 56.56 and a beta of 1.49.

Cognex (NASDAQ:CGNX - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating analysts' consensus estimates of $0.42 by $0.03. The business had revenue of $291.26 million during the quarter, compared to analyst estimates of $292.10 million. Cognex had a net margin of 16.05% and a return on equity of 13.50%. Cognex's quarterly revenue was up 16.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.25 EPS. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. On average, equities research analysts anticipate that Cognex will post 1.68 earnings per share for the current year.

Institutional Trading of Cognex

Large investors have recently bought and sold shares of the company. IFP Advisors Inc lifted its holdings in shares of Cognex by 21.6% in the second quarter. IFP Advisors Inc now owns 956 shares of the scientific and technical instruments company's stock valued at $69,000 after purchasing an additional 170 shares in the last quarter. State of Michigan Retirement System increased its stake in shares of Cognex by 0.5% during the 1st quarter. State of Michigan Retirement System now owns 39,853 shares of the scientific and technical instruments company's stock worth $1,952,000 after purchasing an additional 200 shares in the last quarter. Personal CFO Solutions LLC increased its stake in shares of Cognex by 3.2% during the 1st quarter. Personal CFO Solutions LLC now owns 6,793 shares of the scientific and technical instruments company's stock worth $333,000 after purchasing an additional 212 shares in the last quarter. World Investment Advisors raised its position in shares of Cognex by 3.7% during the 1st quarter. World Investment Advisors now owns 6,073 shares of the scientific and technical instruments company's stock worth $298,000 after purchasing an additional 214 shares during the last quarter. Finally, Essential Partners LLC raised its position in shares of Cognex by 12.5% during the 1st quarter. Essential Partners LLC now owns 2,153 shares of the scientific and technical instruments company's stock worth $105,000 after purchasing an additional 239 shares during the last quarter. 88.12% of the stock is owned by institutional investors.

More Cognex News

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Cognex agreed to acquire RealSense for approximately $500 million. RealSense’s 3D robotic-perception technology could expand Cognex’s addressable market beyond traditional machine vision and support longer-term growth in automation and robotics. Cognex to Acquire RealSense, Expanding Machine Vision Leadership into High-Growth Robotic Perception Market
• Positive Sentiment: Needham initiated Cognex at Buy with an $80 price target, citing the RealSense acquisition and the company’s expanding opportunity in robotic perception. This target implies meaningful upside and supports the view that the deal could accelerate growth. Cognex Initiated at Buy on RealSense Acquisition and Expanding Robotic Perception Growth Opportunity
• Neutral Sentiment: D.A. Davidson maintained a Hold rating and its $65 price target, viewing the RealSense transaction as fairly valued. The unchanged target indicates limited near-term valuation re-rating despite the strategic benefits. Cognex Maintained at Hold as RealSense Deal Seen Fairly Valued
• Negative Sentiment: Robert W. Baird lowered its Cognex price target from $78 to $70 and assigned a Neutral rating. The reduction suggests more cautious expectations for the acquisition’s financial contribution and highlights valuation concerns for a stock trading at a relatively high earnings multiple. Baird Lowers Cognex Price Target

About Cognex

Cognex Corporation NASDAQ: CGNX develops machine vision technologies that help businesses automate inspection, identification, measurement and guidance tasks. Its systems enable manufacturing and logistics operations to analyze images and make decisions about products, components and packages.

The company's product portfolio includes industrial cameras, vision sensors, barcode readers, three-dimensional vision systems and machine vision software. Cognex also offers artificial intelligence and deep-learning tools designed to address complex inspection and classification applications, along with engineering, implementation and support services.

Founded in 1981 by Robert J.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.